CSIMarket
 
Musclepharm Corporation  (MSLP)
Other Ticker:  
 
 

Musclepharm Growth Comparisons

Select each growth Category to receive further Information



MSLP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -0.15 % 24.84 % 19.74 % 14.5 %
Q / Q Revenue Growth (Q1 MRQ) 30.46 % 1.56 % 1.79 % -1.48 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) -18.44 % 25.68 % 21.53 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) -0.04 % 2.97 % 2.79 % 3 %
Revenue 5 Year Average Growth -21.4 % 15.73 % 11.85 % 11.56 %


MSLP's Growth Comparisons in I. Quarter 2022




Although the Major Pharmaceutical Preparations industry saw advancing Revenue by 24.84%, Musclepharm announced -0.15% year on year sales decline in the first quarter 2022, to $ 13 millions, and underperformed the 19.74% Revenue improvement in the Healthcare sector. Although both Major Pharmaceutical Preparations industry and Healthcare sector posted higher gains than 14.5% overall market increase, Musclepharm was trailing overall market in the first quarter.

Company's sequential top-line increase was 30.46% from the forth quarter. Average annual sales rise for Musclepharm is -21.4%, while S & P 500's average yearly sales growth is 11.56% over the five years, including only Businesses with the first quarter 2022 Results.


Growth Rates of MSLP's Income in the first quarter 2022


MSLP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - 39.26 % 14.32 % 14.73 %
Seq. Operating Income Change (Q1 MRQ) - 26.64 % 11.33 % -12.7 %
Y / Y Operating Income Growth (Q1 TTM) - 107.78 % 54.11 % 59.76 %
Seq. Operating Income Growth (Q1 TTM) - 9.87 % 0.4 % 2.49 %
Operating Income 5 Year Avg. Change - 18.78 % 10.14 % 16.38 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - 22.35 % -3.08 % 12.59 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) - 16.95 % 4.07 % 3.2 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 118.33 % 60.1 % 63.82 %
Seq. Income from Cont. Ops. Change (Q1 TTM) - 6.2 % -6.4 % 0.34 %
Income from Cont. Ops. 5 Year Avg. Change - 35.95 % 20.05 % 19.91 %

MSLP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - 21.86 % -3.47 % 13.8 %
Q / Q Net Income Growth (Q1 MRQ) - 18.34 % 5.18 % 3.68 %
Y / Y Net Income Change (Q1 TTM) - 117.08 % 63.33 % 67.8 %
Seq. Net Income Change (Q1 TTM) - 6.09 % -6.49 % 0.66 %
Net Income 5 Year Avg. Growth - 35.78 % 20.22 % 20.18 %

MSLP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - 23.22 % -3.08 % 12.59 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) - 29.32 % 4.07 % 3.2 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) - - - 6640.43 %
EPS from Cont. Ops. 5 Year Avg. Growth - 13.73 % 20.05 % 19.91 %



MSLP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - 22.72 % -3.47 % 19.91 %
Q / Q EPS Net Growth (Q1 MRQ) - 30.85 % 5.18 % 3.68 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 40036.37 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) - - - 55.38 %
EPS Net 5 Year Avg. Change - 35.78 % 20.22 % 20.18 %



Musclepharm reported bottom-line of $ -0.19 in the first quarter, compare to $ 0.00 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 22.72%, while Healthcare sector decreased by -3.47%, and overall market improved by 13.8%.

The company's sequential bottom-line increase was 30.46% from the forth quarter. Average annual income per share rise for Musclepharm is -21.4%, while S & P 500's average yearly income per share growth is 20.18% over the five years, including only Businesses with the first quarter 2022 earnings results.

MSLP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 24.49 % -3.47 % -0.56 %
Seq. Free Cash Flow Change (Q1 MRQ) - 58.58 % 13.16 % -42.06 %
Y / Y Free Cash Flow Change (Q1 TTM) - -12.53 % -9.46 % 35.72 %
Seq. Free Cash Flow Change (Q1 TTM) - -0.46 % -2.84 % -3.7 %
Free Cash Flow 5 Year Avg. Change - 31.36 % 20.48 % 25.45 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - -
Seq. Net Cash Flow Change (Q1 MRQ) - - - -
Y / Y Net Cash Flow Change (Q1 TTM) - - - -85.17 %
Seq. Net Cash Flow Change (Q1 TTM) - - - -60.83 %
Net Cash Flow 5 Year Avg. Change - 58.74 % 86 % 125.83 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) - -3.44 % 2.13 % 11.66 %
Seq. Capital Expenditures Change (Q1 MRQ) - 21.17 % -8.31 % -22.93 %
Y / Y Capital Expenditures Change (Q1 TTM) - -2.73 % 10.76 % 20.71 %
Seq. Capital Expenditures Change (Q1 TTM) - 1.65 % 1.59 % 2.76 %
Capital Expenditures 5 Year Avg. Change - 471.61 % 166.77 % 81.02 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com